Results 71 to 80 of about 107,975 (358)
PROBLEMS IN PHARMACOTHERAPY OF RESISTANT ARTERIAL HYPERTENSION
Российский кардиологический журнал, 2013 The paper focuses on the problems in the treatment of patients with resistant arterial hypertension. The relevant recommendations from the European guidelines are presented.
N. V. Teplova, E. O. Taratukhin
doaj +1 more source
Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes. [PDF]
, 2016 ObjectiveTo compare different blood pressure (BP) levels in their association with the risk of renal outcomes in type 1 diabetes and to determine whether an intensive glycemic control strategy modifies this association.Research design and methodsWe ...
Gitelman, Stephen E +5 more
core +2 more sources
British Journal of Clinical Pharmacology, EarlyView.People accessing aged care services are increasingly older and often experience multimorbidity and polypharmacy, which puts them at risk of medication‐related harm. Quality indicators (QIs) can assist with monitoring, benchmarking and informing initiatives to reduce medication‐related harm.
Daria S. Gutteridge +20 more
wiley +1 more source
Frontiers in Physiology, 2016 Though antihypertensive drugs have been in use for many decades, the mechanisms by which they act chronically to reduce blood pressure remain unclear.
Holly Digne-Malcolm +2 more
doaj +1 more source
Ambulatory blood pressure monitoring in clinical trials with antihypertensive agents [PDF]
, 1995 Ambulatory blood pressure monitoring (ABPM) is being used increasingly for the evaluation of antihypertensive agents in clinical trials. In this brief review several aspects of ABPM are discussed.
Meiracker, A.H. (Anton) van den
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims “Triple whammy” (TW) refers to the concomitant use of diuretics, renin‐angiotensin‐aldosterone system inhibitors (RAASI) and non‐steroidal anti‐inflammatory drugs (NSAIDs). The aim of this article is to analyse the association between TW exposure and acute kidney injury (AKI), among other morbi‐mortality outcomes.
Dulce María Calvo +4 more
wiley +1 more source
Indonesian Journal of Pharmacy, 2010 Hypertension in patients with type 2 diabetes mellitus is a prevalent condition that leads to substantial morbidity and mortality. The aim of the study was to determine the prevalence of hypertension in type 2 diabetes attending ...
Salwa Selim Ibrahim +4 more
doaj +1 more source
Chronopharmacology of antihypertensive agents.
Drug Metabolism and Pharmacokinetics, 1988 There is increasing evidence demonstrating time-dependent changes in effectiveness and toxicity of several agents. Recently we investigated some chronopharmacological aspects of antihypertensive agents such as diuretic, adrenoceptor blocking and calcium channel blocking. We observed that the effects of diuretic agent are greater when it is administered
openaire +3 more sources
Chemistry &Biodiversity, EarlyView.ABSTRACT Plant extracts are emerging as valuable options for food additives and therapeutic treatments. This study evaluated the phytochemical profile, antioxidant activity, and cytotoxicity of aerial parts of Marrubium vulgare L. crude extract (MVCE) and its subfractions.
Ines El Mannoubi +8 more
wiley +1 more source
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients. [PDF]
PLoS ONE, 2013 IntroductionErythropoiesis-Stimulating Agents (ESA) are hypothesized to increase cardiovascular mortality in patients with chronic kidney disease. One of the proposed mechanisms is the elevation of blood pressure (BP) by ESA.
Marit M Suttorp +5 more
doaj +1 more source